Out of 315 samples, 293 samples (93.0%) contained sufficient tumor tissue to allow evaluation of the NRG1 staining in cancer cells, and 289 samples (91.7%) were suitable to address the stromal expression. This evidence concerns the gene NRG1 and cancer.